Macquarie predicts a 20%+ return from this ASX 200 stock

Here's why the broker thinks investors should be snapping up this stock before it's too late.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Macquarie is bullish on this ASX 200 stock, predicting over a 20% return in the next 12 months.
  • The broker has reaffirmed its outperform rating, highlighting 17% potential upside from its current share price and an additional 4.7% dividend yield forecast for FY 2026.
  • Macquarie suggests the company is undervalued, with expected improvements in free cash flow as it moves beyond peak capital expenditures, making it an attractive buy.

If you are hunting big returns for your investment portfolio, then it could be worth checking out the ASX 200 stock in this article.

That's because the team at Macquarie Group Ltd (ASX: MQG) believes it could generate market-beating returns over the next 12 months.

Man drawing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

Which ASX 200 stock?

The stock that Macquarie is bullish on is packaging company Orora Ltd (ASX: ORA).

According to the note, the broker was pleased to see the company reiterate its guidance at this week's annual general meeting. This is being supported by a strong performance from its cans business. It said:

Cans remains the bright spot. We fct cans vols +4% in FY26, in line with LTA along with benefit from Revesby expansion partially offset by higher allocated corp costs. We fct 4% cans EBIT growth in FY26E, accelerating to 10% in FY27E.

Macquarie also highlights that the Saverglass business is performing largely in line with expectations. Though, a large second half skew is expected. The broker adds:

Saverglass (SG) 1Q vols in line with pcp (FY25 vols -12%) with continuation of adverse product mix re wine/champagne (ORA has pursued growth in latter which has lower rev/t vs spirits). FY SG EBIT guidance for flat EBIT is unchanged (this on constant ccy basis hence 1H should see benefit from lower A$). However there's a skew to 2H with lower 1H EBIT vs pcp and stronger expected in 2H due to timing of cost actions from Le Havre closure (=€9m benefit over two years) and modestly higher vols (we fct +2% in 2H26).

Big potential returns

In response to the ASX 200 stock's trading update at its annual general meeting, Macquarie has reaffirmed its outperform rating with a trimmed price target of $2.35 (from $2.40).

Based on the current Orora share price of $2.01, this implies potential upside of 17% for investors over the next 12 months.

In addition, the broker is forecasting a 4.7% dividend yield in FY 2026. This boosts the total potential return to over 21%.

Macquarie thinks investors should be buying this ASX 200 stock while it is undervalued. Particularly given how its free cash flow is expected to improve now that it has move on from its peak capex spend. It concludes:

O/P $2.35 TP. Share price expectations for ORA are relatively low, so FY guidance reiteration was positive in that context albeit with a slightly bigger skew for SG. ORA's free cash flow is set to improve from here as move past peak capex, while buybacks are supportive in the near term.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Orora. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Health professional working on his laptop.
Broker Notes

Are Orthocell shares a buy after crashing 7% yesterday?

These healthcare shares could be on discount right now.

Read more »

a happy man eats pizza in his kitchen with a long string of cheese between the pizza slice in his hand and in his mouth.
Broker Notes

Buy, hold, sell: Collins Foods, Domino's, and Guzman Y Gomez shares

Bell Potter has given its verdict on these popular shares this morning.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Why WiseTech shares could rise 70%

Bell Potter is urging investors to buy this tech stock before it rebounds.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Broker Notes

Why this surging ASX All Ords stock is forecast to rocket another 142%

A leading broker expects this ASX gold stock could more than double investors’ money in the year ahead.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Brokers name 2 skyrocketing ASX energy shares to buy today

Top brokers forecast further strong outperformance from these two surging ASX energy stocks. But why?

Read more »

Two brokers pointing and analysing a share price.
Broker Notes

Buy, hold, sell: Xero, Woolworths, CBA shares

Here's what the experts think of these sector giants.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

NextDC vs Wesfarmers shares: Which is a buy?

Analysts have given their verdict on these shares this week.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »